theophylline has been researched along with Cancer of Head in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vallurupalli, S | 1 |
| Aggarwal, C | 1 |
| Sewani, A | 1 |
| Paydak, H | 1 |
| Kulsum, S | 1 |
| Sudheendra, HV | 1 |
| Pandian, R | 1 |
| Ravindra, DR | 1 |
| Siddappa, G | 1 |
| R, N | 1 |
| Chevour, P | 1 |
| Ramachandran, B | 1 |
| Sagar, M | 1 |
| Jayaprakash, A | 1 |
| Mehta, A | 1 |
| Kekatpure, V | 1 |
| Hedne, N | 1 |
| Kuriakose, MA | 1 |
| Suresh, A | 1 |
2 other studies available for theophylline and Cancer of Head
| Article | Year |
|---|---|
Oral theophylline as temporizing treatment of neck mass induced carotid sinus syncope.
Topics: Administration, Oral; Head and Neck Neoplasms; Humans; Male; Middle Aged; Syncope; Theophylline; Tre | 2013 |
Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase 1 Family; Antineoplastic Agents; Carcinoma, Squamous | 2017 |